December 19, 2024 Glycosyn announces the availability for licensing of its commercial high-titer human milk oligosaccharide (HMO) production strains, and IP covering prebiotic, anti-inflammatory and anti-infective uses of HMOs
November 8, 2018 Ginkgo Bioworks and Glycosyn LLC Announce $14MM Deal to Scale Production of Human Milk Oligosaccharides
